A review of genetic, biological, pharmacological, and clinical factors that affect carbohydrate-deficient transferrin levels.

doi:10.1097/01.alc.0000139815.89794.be

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

A review of genetic, biological, pharmacological, and clinical factors that affect carbohydrate-deficient transferrin levels.

Alcoholism, clinical and experimental research - 1 Sept 2004

Fleming Michael F, Anton Raymond F, Spies Claudia D

Abstract excerpt

BACKGROUND: Carbohydrate-deficient transferrin (CDT) is an alcohol biomarker recently approved by the U.S. Food and Drug Administration. This test is increasingly being used to detect and monitor alcohol use in a variety of health care, legal, and industrial settings. The goal of this study is to review the genetic, biological, pharmacological, and clinical factors that may affect CDT levels. METHODS: A review of...

Topics

Age Factors
Alcoholism
Genetic Variation
Humans
Pharmaceutical Preparations
Sex Characteristics
Transferrin

Source

Open in PubMed

Identifiers

PMID: 15365305
DOI: 10.1097/01.alc.0000139815.89794.be

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics